Deidra Edison, MED in Ashtabula, OH - Counselor

Deidra Edison, MED is a Counselor - Addiction (substance Use Disorder) based in Ashtabula, Ohio. Deidra Edison is licensed to practice in * (Not Available) (license number ) and her current practice location is 2801 C Ct, Ashtabula, Ohio. She can be reached at her office (for appointments etc.) via phone at (440) 998-0722.

NPI number for Deidra Edison is 1861812034 and her current mailing address is 2801 C Ct, Ashtabula, Ohio. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1861812034.

Contact Information

	Deidra Edison, MED
	2801 C Ct, Ashtabula, OH 44004-4577
	(440) 998-0722
	Not Available

Healthcare Provider's Profile

Full Name	Deidra Edison
Gender	Female
Speciality	Counselor - Addiction (substance Use Disorder)
Location	2801 C Ct, Ashtabula, Ohio
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1861812034
Provider Enumeration Date: 04/25/2014
Last Update Date: 03/05/2024

Medical Identifiers

Medical identifiers for Deidra Edison such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1861812034	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TS0200X	Psychologist - School	OH3127884 (Ohio)	Secondary
101YA0400X	Counselor - Addiction (substance Use Disorder)	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Deidra Edison is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Deidra Edison, MED 2801 C Ct, Ashtabula, OH 44004-4577 Ph: (440) 998-0722	Deidra Edison, MED 2801 C Ct, Ashtabula, OH 44004-4577 Ph: (440) 998-0722

News Archive

SARS-CoV-2 spike protein triggers cell signaling pathways in lung vascular cells

A new study published on the preprint server bioRxiv in October 2020 shows that vascular cells in the lung tissue begin to secrete signaling growth factors when exposed to just the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), without the rest of the viral components.

Specific lipids in tumours linked to cancer progression and patient survival

Activation of lipid metabolism is an early event in carcinogenesis and a central hallmark of many cancers. However, the precise molecular composition of lipids in tumours remains generally poorly characterised. Scientists from VTT Technical Research Centre of Finland and the Charité Hospital have found lipids in tumours which are associated with cancer progression.

Refinements to CTC-chip may better monitor how CTC levels react to prostate cancer treatment

Technical improvements to a microchip-based device for detecting and analyzing tumor cells in the bloodstream are revealing cellular differences that may reflect a tumor's aggressiveness and long-term response to treatment.

Qutenza 8% patch now available for pain associated with PHN: NeurogesX

NeurogesX, Inc. announced today that Qutenza® (capsaicin) 8% patch, the first and only product containing prescription-strength capsaicin, is now available. Clinical studies have shown that a single one-hour Qutenza application can provide three months relief from pain associated with postherpetic neuralgia, the nerve pain that can occur after shingles.

Deidra Edison, MED - in Ashtabula, OH